BioXcel Therapeutics
Earnings Surprise
Analysts estimated BTAI earnings of $-0.77 per share this quarter (Q4). BTAI's actual earnings were $-0.58 per share.
BTAI EPS surprise of 24.18%Analysts estimated BTAI earnings of $-1.20 per share this quarter (Q3). BTAI's actual earnings were $-2.18 per share.
BTAI EPS surprise of -81.50%Analysts estimated BTAI earnings of $-1.89 per share this quarter (Q2). BTAI's actual earnings were $-2.45 per share.
BTAI EPS surprise of -29.42%Analysts estimated BTAI earnings of $-6.79 per share this quarter (Q1). BTAI's actual earnings were $-1.50 per share.
BTAI EPS surprise of 77.91%Analysts estimated BTAI earnings of $-6.55 per share this quarter (Q4). BTAI's actual earnings were $-3.57 per share.
BTAI EPS surprise of 45.53%Analysts estimated BTAI earnings of $-8.84 per share this quarter (Q3). BTAI's actual earnings were $-5.12 per share.
BTAI EPS surprise of 42.08%Analysts estimated BTAI earnings of $-0.72 per share this quarter (Q2). BTAI's actual earnings were $-0.21 per share.
BTAI EPS surprise of 71.00%Analysts estimated BTAI earnings of $-0.71 per share this quarter (Q1). BTAI's actual earnings were $-0.87 per share.
BTAI EPS surprise of -22.14%Analysts estimated BTAI earnings of $-0.93 per share this quarter (Q4). BTAI's actual earnings were $-0.76 per share.
BTAI EPS surprise of -18.12%Analysts estimated BTAI earnings of $-1.33 per share this quarter (Q3). BTAI's actual earnings were $-1.72 per share.
BTAI EPS surprise of 29.31%